{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T01:43:20Z","timestamp":1791855800052,"version":"4.3.4"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2012,12,28]],"date-time":"2012-12-28T00:00:00Z","timestamp":1356652800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s00431-012-1913-3","type":"journal-article","created":{"date-parts":[[2012,12,27]],"date-time":"2012-12-27T09:06:36Z","timestamp":1356599196000},"page":"513-518","source":"Crossref","is-referenced-by-count":51,"title":["Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab"],"prefix":"10.1007","volume":"172","author":[{"given":"Shuichiro","family":"Fujinaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomonosuke","family":"Someya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneki","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Ohtomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiaki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunari","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,28]]},"reference":[{"key":"1913_CR1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1007\/s00467-003-1175-4","volume":"18","author":"GM Barletta","year":"2003","unstructured":"Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndrome. Pediatr Nephrol 18:833\u2013837","journal-title":"Pediatr Nephrol"},{"key":"1913_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s00467-004-1434-z","volume":"19","author":"K Benz","year":"2004","unstructured":"Benz K, D\u00f6tsch J, Rascher W, Stachel D (2004) Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy. Pediatr Nephrol 19:794\u2013797","journal-title":"Pediatr Nephrol"},{"key":"1913_CR3","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s00467-011-1894-x","volume":"26","author":"G Filler","year":"2011","unstructured":"Filler G, Huang SH, Sharma AP (2011) Should we consider MMF therapy after rituximab for nephrotic syndrome? Pediatr Nephrol 26:1759\u20131762","journal-title":"Pediatr Nephrol"},{"key":"1913_CR4","first-page":"962","volume":"19","author":"G Filler","year":"2004","unstructured":"Filler G, Lepage N (2004) To what extent dose the understanding of pharmacokinetics of mycophenolate mofetil influence its prescription. Pediatr Nephrol 19:962\u2013965","journal-title":"Pediatr Nephrol"},{"key":"1913_CR5","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","volume":"25","author":"S Fujinaga","year":"2010","unstructured":"Fujinaga S, Hirano D, Nishizaki N, Kamei K, Ito S, Ohtomo Y, Shimizu T, Kaneko K (2010) Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine. Pediatr Nephrol 25:539\u2013544","journal-title":"Pediatr Nephrol"},{"key":"1913_CR6","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/adc.2005.080960","volume":"91","author":"S Fujinaga","year":"2006","unstructured":"Fujinaga S, Kaneko K, Muto T, Ohtomo Y, Murakami H, Yamashiro Y (2006) Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome. Arch Dis Child 91:666\u2013670","journal-title":"Arch Dis Child"},{"key":"1913_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","volume":"22","author":"S Fujinaga","year":"2007","unstructured":"Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K (2007) A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol 22:71\u201376","journal-title":"Pediatr Nephrol"},{"key":"1913_CR8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00467-003-1300-4","volume":"19","author":"J Gellermann","year":"2004","unstructured":"Gellermann J, Querfeld U (2004) Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil. Pediatr Nephrol 19:101\u2013104","journal-title":"Pediatr Nephrol"},{"key":"1913_CR9","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00467-008-0814-1","volume":"23","author":"V Guigonis","year":"2008","unstructured":"Guigonis V, Dallocchio A, Baudouin V, Dehennault M, Hachon-Le Camus C, Afanetti M, Groothoff J, Llanas B, Niaudet P, Nivet H, Raynaud N, Taque S, Ronco P, Bouissou F (2008) Rituximab treatment for severe steroid- or cyclosporine-dependent nephrotic syndrome: a multicentric series of 22 cases. Pediatr Nephrol 23:1269\u20131279","journal-title":"Pediatr Nephrol"},{"key":"1913_CR10","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","volume":"5","author":"A Gulati","year":"2010","unstructured":"Gulati A, Sinha A, Jordan SC, Hari P, Dinda AK, Sharma S, Srivastava RN, Moudgil A, Bagga A (2010) Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: multicentric report. Clin J Am Soc Nephrol 5:2207\u20132212","journal-title":"Clin J Am Soc Nephrol"},{"key":"1913_CR11","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1442-200X.2011.03432.x","volume":"53","author":"K Iijima","year":"2011","unstructured":"Iijima K (2011) Rituximab for childhood refractory nephrotic syndrome. Pediatr Int 53:617\u2013621","journal-title":"Pediatr Int"},{"key":"1913_CR12","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1046\/j.1523-1755.2002.00303.x","volume":"61","author":"K Iijima","year":"2002","unstructured":"Iijima K, Hamahira K, Tanaka R, Kobayashi A, Nozu K, Nakamura H, Yoshikawa N (2002) Risk factors for cyclosporine-induced tubulointerstitial lesions in children with minimal change nephrotic syndrome. Kidney Int 61:1801\u20131805","journal-title":"Kidney Int"},{"key":"1913_CR13","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1093\/ndt\/gfq318","volume":"25","author":"K Ishikura","year":"2010","unstructured":"Ishikura K, Yoshikawa N, Hattori S, Sasaki S, Iijima K, Nakanishi K, Matsuyama T, Yata N, Ando T, Honda M (2010) Treatment with microemulsified cyclosporine in children with frequently relapsing nephrotic syndrome. Nephrol Dial Transplant 25:3956\u20133962","journal-title":"Nephrol Dial Transplant"},{"key":"1913_CR14","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00467-011-1886-x","volume":"26","author":"S Ito","year":"2011","unstructured":"Ito S, Kamei K, Ogura M, Sato M, Fujimaru T, Ishikawa T, Udagawa T, Iijima K (2011) Maintenance therapy with mycophenolate mofetil after rituximab in pediatric patients with steroid-dependent nephrotic syndrome. Pediatr Nephrol 26:1823\u20131828","journal-title":"Pediatr Nephrol"},{"key":"1913_CR15","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","volume":"24","author":"K Kamei","year":"2009","unstructured":"Kamei K, Ito S, Nozu K, Fujinaga S, Nakayama M, Sako M, Saito M, Yoneko M, Iijima K (2009) Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children. Pediatr Nephrol 24:1321\u20131328","journal-title":"Pediatr Nephrol"},{"key":"1913_CR16","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","volume":"27","author":"MJ Kemper","year":"2012","unstructured":"Kemper MJ, Gellermann J, Habbig S, Krmar RT, Dittrich K, Jungraithmayr T, Pape L, Patzer L, Billing H, Weber L, Pohl M, Rosenthal K, Rosahl A, Mueller-Wiefel DE, D\u00f6tsch J (2012) Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant 27:1910\u20131915","journal-title":"Nephrol Dial Transplant"},{"key":"1913_CR17","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s00467-005-1877-x","volume":"20","author":"S Mendiz\u00e1bal","year":"2005","unstructured":"Mendiz\u00e1bal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J (2005) Mycophenolate mofetil in steroid\/cyclosporine-dependent\/resistant nephrotic syndrome. Pediatr Nephrol 20:914\u2013919","journal-title":"Pediatr Nephrol"},{"key":"1913_CR18","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1248\/bpb.30.2371","volume":"30","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, Nozu K, Iijima K, Yoshikawa N, Morita Y, Yamamori M, Kako A, Matsuo M, Sakurai A, Okamura N, Ishikawa T, Okumura K, Sakaeda T (2007) Association of cumulative cyclosporine dose with its irreversible nephrotoxicity in Japanese patients with pediatric-onset autoimmune disease. Biol Pharm Bull 30:2371\u20132375","journal-title":"Biol Pharm Bull"},{"key":"1913_CR19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1007\/s00467-002-0896-0","volume":"17","author":"VK Sairam","year":"2002","unstructured":"Sairam VK, Kalia A, Rajaraman S, Travis LB (2002) Secondary resistance to cyclosporine A in children with nephrotic syndrome. Pediatr Nephrol 17:842\u2013846","journal-title":"Pediatr Nephrol"},{"key":"1913_CR20","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","volume":"27","author":"AL Sellier-Leclerc","year":"2012","unstructured":"Sellier-Leclerc AL, Baudouin V, Kwon T, Macher MA, Gu\u00e9rin V, Lapillonne H, Desch\u00eanes G, Ulinski T (2012) Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood\u2014follow-up after CD19 recovery. Nephrol Dial Transplant 27:1083\u20131089","journal-title":"Nephrol Dial Transplant"},{"key":"1913_CR21","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s00467-004-1778-4","volume":"20","author":"T Ulinski","year":"2005","unstructured":"Ulinski T, Dubourg L, Said MH, Parchoux B, Ranchin B, Cochat P (2005) Switch from cyclosporine A to mycophenolate mofetil in nephrotic children. Pediatr Nephrol 20:482\u2013485","journal-title":"Pediatr Nephrol"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-012-1913-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00431-012-1913-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-012-1913-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T22:22:19Z","timestamp":1559082139000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00431-012-1913-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,28]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["1913"],"URL":"https:\/\/doi.org\/10.1007\/s00431-012-1913-3","relation":{},"ISSN":["0340-6199","1432-1076"],"issn-type":[{"value":"0340-6199","type":"print"},{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,28]]}}}